SARS-CoV-2 viral dynamics and population pharmacokinetics of favipiravir in combination with lopinavir-ritonavir in patients with COVID-19

被引：0
|
作者：
Agyeman, Akosua A. [1 ]
Brown, Li-An K. [2 ]
Guerra-Assuncao, Jose A.
Breuer, Judy [1 ,3 ]
Lowe, David M. [2 ,4 ]
Standing, Joseph F. [1 ,5 ]
机构：
[1] UCL, Great Ormond St Inst Child Hlth, Infect Immun & Inflammat Res & Teaching Dept, London, England
[2] UCL, Inst Immun & Transplantat, Royal Free Campus, London, England
[3] Great Ormond St Hosp Sick Children, Dept Microbiol, London, England
[4] Royal Free London NHS Fdn Trust, Dept Clin Immunol, London, England
[5] Great Ormond St Hosp Sick Children, Dept Pharm, London, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0348
引用
收藏
页码：291 / 294
页数：4
相关论文
共 50 条
  • [1] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Alvarez, Jean Claude
    Moine, Pierre
    Davido, Benjamin
    Etting, Isabelle
    Annane, Djillali
    Larabi, Islam Amine
    Simon, Nicolas
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (03) : 389 - 397
  • [2] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Jean Claude Alvarez
    Pierre Moine
    Benjamin Davido
    Isabelle Etting
    Djillali Annane
    Islam Amine Larabi
    Nicolas Simon
    European Journal of Clinical Pharmacology, 2021, 77 : 389 - 397
  • [3] A Trial of Lopinavir-Ritonavir in Covid-19
    Carmona-Bayonas, Alberto
    Jimenez-Fonseca, Paula
    Castanon, Eduardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
  • [4] The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment
    Cinarka, Halit
    Gunluoglu, Gulsah
    Cortuk, Mustafa
    Yurt, Sibel
    Kiyik, Murat
    Kosar, Filiz
    Tanriverdi, Elif
    Arslan, Melih Akay
    Baydili, Kursad Nuri
    Koc, Aysu Sinem
    Altin, Sedat
    Cetinkaya, Erdogan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1624 - 1630
  • [5] Lopinavir-ritonavir in severe COVID-19
    Stower, Hannah
    NATURE MEDICINE, 2020, 26 (04) : 465 - 465
  • [6] Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19
    Lv, Xiu-He
    Yang, Jin-Lin
    Deng, Kai
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (05): : 1099 - 1099
  • [7] A Trial of Lopinavir-Ritonavir in Covid-19 Reply
    Cao, Bin
    Zhang, Dingyu
    Wang, Chen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
  • [8] BET 1: LOPINAVIR-RITONAVIR AND COVID-19
    Dolan, Daniel
    Ingham, Jack
    Baombe, Janos
    EMERGENCY MEDICINE JOURNAL, 2020, 37 (07) : 450 - +
  • [9] No Benefit for Lopinavir-Ritonavir in Severe COVID-19
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20): : 1999 - 1999
  • [10] Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir
    Manosuthi, Weerawat
    Jeungsmarn, Somlerk
    Okada, Pilailuk
    Suwanvattana, Pawita
    Wongboot, Warawan
    Thawornwan, Unchana
    Charoenpong, Lantharita
    Wiboonchutikul, Surasak
    Uttayamakul, Sumonmal
    Pongpirul, Wannarat A.
    Wachirapan, Apichat
    Warachit, Paijit
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2021, 74 (05) : 416 - 420
12345